Clinical Trial Update: Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety, tolerability, and immunogenicity of the MenABCWY vaccine administered on different dosing schedules in healthy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• MenABCWY

Snippet

Sponsor: GlaxoSmithKline | Conditions: Meningitis, Meningococcal | Phase 2 | Status: ACTIVE_NOT_RECRUITING